HCM
MRNA icon

Highlander Capital Management’s Moderna MRNA Stock Holding History

Highlander Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$7K – 619
2021
Q1 		$7K Hold
50
– – ﹤0.01% 519
2020
Q4 		$5K Buy
+50
New +$5.06K ﹤0.01% 533
2020
Q3 		– Sell
-300
Closed -$19K – 615
2020
Q2 		$19K Buy
+300
New +$16.4K 0.01% 413

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Highlander Capital Management's MRNA Position: Q2 2021 in Review

Highlander Capital Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 50 shares — an estimated $7K sold.

Highlander Capital Management first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $19K in Q2 2020. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Highlander Capital Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Highlander Capital Management sold 50 Moderna shares in Q2 2021, an estimated $7K.
  • Highlander Capital Management first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
  • Highlander Capital Management's Moderna position peaked at $19K in Q2 2020.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Highlander Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.